BioWorld

Sep. 14, 2004

DNA Vaccine Might Provide Immunity Against Anthrax

FDA Panel Evaluates SSRIs, Risk Of Suicidal Thoughts

ID Biomedical's Government Contract Worth Up To C$30M

Other News To Note

Chiron Settles With Roche For $78M, Licenses IP To InterMune

Chiron Corp. finalized a settlement agreement with F. Hoffmann-La Roche Ltd. concerning an HIV patent late last week, then announced Monday an agreement to provide InterMune Inc. with its hepatitis C targets. (BioWorld Today) Read More

Threshold Starts Glufosfamide Phase III In Pancreatic Cancer

Today's news in brief

BioWorld

BioWorld briefs for June 9, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...

Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors

BioWorld Science

Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.

Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors

BioWorld Science

Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...